Anew Medical Stock Forum

ANEW MEDICAL, INC.: Pioneering Genetic Therapy for Neurodegenerative Diseases.
ANEW MEDICAL, INC. (NASDAQ: WENA), a biotechnology company based in the United States, has announced significant advancements in its mission to develop genetic therapies aimed at combating neurodegenerative diseases. Recently, the company was granted patents in major Asian markets, specifically Hong Kong and China, for its groundbreaki...

$Anew Medical (WENA.US)$ Patents issued in mainland China protect the Company's novel secreted Klotho protein and Its gene delivery system
Recent Patents issued in Hong Kong and Shanghai support protection to develop treatments for Alzheimer's Disease and other neurodegenerative diseases

$Anew Medical (WENA.US)$ The Company previously announced that it had been granted this key patent in China (Patent No. CN 117126829A) for the use of ANEW's Klotho protein and Klotho gene delivery and expression systems in the treatment of cognition, memory and neurodegenerative diseases. This intellectual property was licensed by ANEW from UNIVERSITAT AUTÒNOMA DE BARCELONA (UAB) and INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS (ICREA) in Barcelona, Spain on an exclusive worldwide basis.

$Anew Medical (WENA.US)$ The aging population in China is affected by the same age-related diseases we are fighting in the US and Europe. According to a recent report, China has the highest number of Alzheimer's patients in the world, with nearly 10 million people aged 60 and older suffering from the disease. Additionally, Asia in general is experiencing the fastest growth in the elderly population is taking place. Japan is considered a "super-aging" country, and the number of people with AD in ...